GL1X · GenesisL1 explorer

MolNFT v1 · #113500 · protein

Disubstituted bis-thf moieties as new P2 ligands in non-peptidal HIV- 1 protease inhibitors (II)

5AHA: “Disubstituted bis-thf moieties as new P2 ligands in non-peptidal HIV- 1 protease inhibitors (II)”. X-ray diffraction, 2 ligands (ZLP, CL), 1 pocket (best druggability 0.73). MolNFT v1 #113500 on GenesisL1: 3D structure, binding…

PDB
5AHA
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
UniProt
P03366
Ligands
ZLP, CL
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein994% helix, 56% strandP03366

Ligands and binding sites

  • ZLP · (3R,3aS,4R,6aR)-4-(2-methoxyethoxy)hexahydrofuro[2,3-b]furan-3-yl {(2S,3R)-3-hydroxy-4-[{[(2Z)-2-(methylimino)-2,3-dihydro-1,3-benzoxazol-6-yl]sulfonyl}(2-methylpropyl)amino]-1-phenylbutan-2-yl}carbamate · ligand · chains A, B
  • CL · Chloride ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14560.730.8344ZLP

Interfaces

1 interface between chains.

  • A–B · 1834 Ų buried · 42 hydrogen bonds · protein-protein

Compared structures

  • 5AHA · Disubstituted bis-THF moieties as new P2 ligands in non-peptidal HIV- 1 Protease… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.